The global Patient Registry Software Market is expected to reach US$ 4.4 Bn in 2031, growing at a compound annual growth rate (CAGR) of 17.5% during the forecast period of 2024-2031. Patient registry software is a specialized healthcare IT solution designed to collect, store, and analyze data related to patients with specific medical conditions or undergoing specific treatments. These software solutions play a crucial role in facilitating long-term patient monitoring, disease management, and real-world evidence generation, which is driving their adoption across the healthcare industry.

The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and diabetes, is a significant driver for the patient registry software market. As the global burden of chronic conditions continues to rise, the need for effective disease management tools and patient-centric care approaches is fueling the demand for these software solutions. Additionally, the growing emphasis on value-based care models and the utilization of real-world evidence (RWE) in healthcare decision-making are further propelling the adoption of patient registry software.

The market is witnessing a surge in growth opportunities driven by several factors, including the integration of advanced technologies like artificial intelligence (AI) and machine learning, the expansion into emerging markets with rapidly developing healthcare infrastructure, and the growing focus on rare disease and orphan drug management. Moreover, collaborations between patient registry software providers and pharmaceutical companies are opening new avenues for data sharing, co-development of tailored solutions, and leveraging valuable patient insights for drug development and post-marketing surveillance.

Drivers:

1. Rising Prevalence of Chronic Diseases: The increasing global burden of chronic diseases, such as cancer, cardiovascular diseases, diabetes, and respiratory conditions, is driving the demand for patient registry software. These solutions enable healthcare providers to collect, analyze, and monitor patient data over an extended period, facilitating effective disease management and improving treatment outcomes. According to the World Health Organization (WHO), chronic diseases account for 73% of global deaths, highlighting the urgent need for comprehensive disease management strategies.
2. Growing Focus on Real-World Evidence (RWE) and Value-Based Care: The healthcare industry is shifting towards value-based care models, where treatment decisions and reimbursement strategies are driven by real-world evidence (RWE) and patient outcomes. Patient registry software plays a pivotal role in generating RWE by capturing and analyzing data from diverse sources, including electronic health records (EHRs), patient-reported outcomes, and clinical trials. This data can inform evidence-based decision-making and support value-based care initiatives.

Trends:

1. Adoption of Cloud-Based and Software-as-a-Service (SaaS) Deployment Models.
2. Increasing Focus on Patient Engagement and Patient-Reported Outcomes (PROs).

Market Opportunity:

Integration of Artificial Intelligence (AI) and Advanced Analytics into Patient Registry Software.

Key Report Insights:

• North America is expected to be the largest market for the Patient Registry Software Market, accounting for over 38.2% of the market share in 2023. Prominent companies with a strong presence in the region include Quintiles IMS Holdings, Inc. (IQVIA), Optum, Inc. (UnitedHealth Group), and McKesson Corporation. The growth of the market in North America is attributed to the well-established healthcare infrastructure, high adoption of electronic health records (EHRs), and a strong focus on real-world evidence generation and personalized medicine.
• Europe is expected to be the second-largest market for the Patient Registry Software Market, accounting for over 27.5% of the market share in 2023. Major companies operating in the region include Phytel, Inc. (IBM Corporation), Evado Clinical Solutions, and QPID Health. The growth of the market in Europe is driven by the presence of leading healthcare providers, stringent regulatory requirements for data collection and management, and increasing investments in healthcare IT infrastructure.
• Prominent companies present in the Patient Registry Software Market include Quintiles IMS Holdings, Inc. (IQVIA), Optum, Inc. (UnitedHealth Group), FIGmd, Inc., McKesson Corporation, Phytel, Inc. (IBM Corporation), Evado Clinical Solutions, ImageTrend, Inc., QPID Health, Velos, Inc., and Liaison Technologies.

Market Segmentation:

• By Software Type
  • Integrated
  • Standalone
• By Delivery Mode
  • On-premises
  • Web-based
  • Cloud-based
  • Hybrid
  • Others (Mobile-based, Virtual)
• By Database Type
  • Public
  • Private
  • Hybrid
• By Functionality
  • Population Health Management
  • Patient Care Management
  • Health Information Exchange
  • Point-of-Care
  • Product Outcome Evaluation
  • Disease Reporting
  • Others (Medication Use, Clinical Trial Recruitment)
• By Pricing Model
  • Subscription-based
  • Perpetual Licensing
  • Usage-based
  • Freemium
• By End-User
  • Healthcare Providers
  • Government & Third-Party Administrators
  • Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Insurance Payers
• By Application
  • Chronic Disease Management
  • Rare Disease Management
  • Drug Safety Surveillance
  • Clinical Trial Recruitment and Management
  • Post-Marketing Surveillance
  • Outcome Research
  • Others (Disease Registries, Registries for Specific Procedures)
• By Region
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Definition:

“Patient registry software is a specialized software solution designed to collect, store, and analyze data related to patients with specific medical conditions or undergoing specific treatments. It enables healthcare providers and researchers to track patient outcomes, monitor disease progression, identify potential safety concerns or treatment efficacy, and facilitate long-term patient monitoring. These software solutions help streamline data collection processes, improve data accuracy, and generate real-world evidence for healthcare decision-making, disease management, and personalized medicine approaches.”